Posts Tagged ‘Tomosynthesis’

In a long-anticipated move, this past Wednesday GE spun out its healthcare division with a listing on the NASDAQ stock exchange. After […]

Eleven years ago, we reviewed the Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer, by oncologist Dr Siddhartha Mukherjee (© […]

Digital breast tomosynthesis (DBT) was approved by the FDA in 2011 as a screening modality for the early detection of […]

On Wednesday this week, Hologic released its second annual global women’s health index (GWHI), which provides a framework for achieving comprehensive progress. […]

The European Innovation Council, under the umbrella of its Pathfinder Programme, has recently awarded a grant of €2.7 million to a […]

Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]

Five years ago, we reported that the United States Patent and Trademark Office (USPTO) had awarded CapeRay a key patent to protect our novel dual-modality […]

In 1985, Dr Jay Stein and his good friend David Ellenbogen teamed up to co-found Hologic with 12 employees and the intention […]

It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]

It is widely accepted that when breast cancer is diagnosed early and remains localised, effective treatment yields a five-year survival […]